Planet DDS vs Eli Lilly
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cloud-native dental practice management including Denticon for DSOs and Apteryx XVWeb for cloud imaging. Irvine CA; founded 2003;
About
Planet DDS is an Irvine, California-based cloud-native dental software company that offers an integrated suite of tools for dental practices, DSOs, and dental imaging, with Denticon as its flagship cloud practice management system and Apteryx XVWeb as its cloud imaging platform. Founded in 2003, Planet DDS built Denticon as one of the first true multi-site, cloud-based dental practice management systems at a time when the market was dominated by legacy on-premise software. Denticon's multi-location architecture allows DSOs and group practices to manage enterprise-level functions—credentialing, reporting, fee schedule management, and patient record sharing across locations—from a centralized cloud platform rather than managing separate on-premise installations at each site.\n\nPlanet DDS has doubled down on the DSO market, where its cloud architecture offers significant operational advantages over legacy systems that require local servers, manual software updates, and location-by-location IT support. The company's acquisition of Apteryx, a dental imaging software business, extended its platform into digital radiography management, allowing practices to manage both clinical workflows and imaging through an integrated cloud environment. Planet DDS also acquired Legwork in 2021, a dental patient communication and marketing platform, adding patient engagement, online scheduling, and reputation management capabilities to its suite.\n\nThe DSO market has been growing rapidly as dental consolidation accelerates, and Planet DDS is positioned to benefit from practices migrating away from Dentrix and Eaglesoft to cloud-native platforms that can scale with multi-location growth. The company integrates with dental imaging sensors, intraoral cameras, and third-party lab management systems. Planet DDS competes with Carestream Dental, Curve Dental, and the Carestream/Apteryx imaging market alongside practice management leaders Dentrix and Eaglesoft, which are owned by Henry Schein.
Indianapolis global pharma (NYSE: LLY) at $45B 2024 revenue (+32%); first healthcare company to $1T market cap (Nov 2024) with Mounjaro/Zepbound tirzepatide (37% revenue) and oral GLP-1 orforglipron Phase 3 competing with Novo Nordisk.
About
Eli Lilly and Company is an Indianapolis, Indiana-based global pharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: LLY) as an S&P 500 Dow Jones Industrial Average component — that in November 2024 became the world's most valuable pharmaceutical company with a historic $1 trillion market capitalization, the first healthcare company ever to reach this milestone. In fiscal year 2024, Lilly achieved approximately $45 billion in revenue, representing 32% growth from 2023, driven by blockbuster GLP-1 medications tirzepatide (Mounjaro for type 2 diabetes and Zepbound for obesity and obstructive sleep apnea), which together accounted for 37% of 2024 revenues. Other key products include Trulicity (dulaglutide, 12% of revenue), Humalog (insulin lispro, 5%), and Kisunla (donanemab), the first new Alzheimer's therapy approved for early symptomatic disease in 2024. An oral GLP-1 pill (orforglipron) is in Phase 3 clinical trials. CEO David Ricks has led the company since 2017. Founded in 1876 by Colonel Eli Lilly in Indianapolis, the company pioneered mass production of Jonas Salk's polio vaccine in 1955 and was among the first to produce human insulin using recombinant DNA technology.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.